ReviewMolecular biology reports2025
Exosomes and their role in gastric cancer caused by Helicobacter pylori.
Review in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advances inOncology letters · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Helicobacter pylori (H. pylori) is one of the main pathogens linked to the etiology of gastric cancer (GC) and the cause of a large portion of the world's disease burden. Exosomes, small extracellular vesicles, play a crucial role in the pathogenesis and progression of GC through their unique RNA cargo. Exosomes produced from H. pylori-infected cells carry bioactive chemicals such as MicroRNA (miRNAs), that rewire recipient cells, so modulating immune responses, promoting angiogenesis, facilitating metastasis, and contributing to treatment resistance. Here, the role of H. pylori in GC is discussed, with a focus on H. pylori-induced exosomal miRNAs in pathogenesis through regulation of gene expression, inflammatory responses, and the tumor microenvironment. This review underscores the importance of exosome-mediated cross-talk in H. pylori-induced GC as predictive diagnostic biomarkers. Moreover, their potential use in treatment approaches and the need for further research into exosome-based therapeutic strategies will be highlight.
Indexed as
Identifiers
41045374What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.